Please login to the form below

Amryt

This page shows the latest Amryt news and features for those working in and with pharma, biotech and healthcare.

Amryt Pharma’s Lojuxta (lomitapide) for homozygous familial hypercholesterolaemia (HoFH) was ranked as a Level 3.

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Amryt Pharma appoints Jordi Casals as head of Europe

Dr Joe Wiley, chief executive officer of Amryt, said: “I am pleased to welcome Jordi to our senior management team as the company’s head of Europe. ... His significant commercial experience of European markets will help us to drive and further
Amryt Pharma appoints new regulatory affairs head

Prior to joining Amryt, she served as senior director of regulatory affairs for rare disease group Retrophin. ... Her new role will see her take responsibility for engagement with regulatory agencies and she will examine opportunities to pursue new

More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.

FREELANCE Account Director – Healthcare Advertising – London – 3...: Competitive Daily Rates

Senior Account Manager > Account Director - London - Medical ...: Salary TBC

Senior Account Executive – Account Manager – Healthcare Advertis...: £32000 - £43000 Bonus Benfits

Account Director - Healthcare Advertising - London - 2 DAYS HOME...: £50000 - £70000

Add my company

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

A uniquely English genomic medicine service: The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence: Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value: Patient Involvement in Health Technology Assessment: Exploring the evolution of patient involvement in health technology assessment (HTA), and the role of the patient voice in market access....